Zenith Healthcare (BOM:530665) Interest Expense: ₹-0.1 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530665 Zenith Healthcare Ltd BOM:530665
61 GF Score
Price ₹3.09
GF Value ₹3.62
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zenith Healthcare Interest Expense?

Zenith Healthcare BOM:530665 +0.65% 61 Interest Expense is ₹-0.1 Mil as of Mar. 2026. GuruFocus rates BOM:530665 with a GF Score™ of 61/100 and a GF Value™ of ₹3.62 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Zenith Healthcare's interest expense for the three months ended in Mar. 2026 was ₹ -0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-0.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Zenith Healthcare's Operating Income for the three months ended in Mar. 2026 was ₹ -5.2 Mil. Zenith Healthcare's Interest Expense for the three months ended in Mar. 2026 was ₹ -0.0 Mil. Zenith Healthcare did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zenith Healthcare  (BOM:530665) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zenith Healthcare's Interest Expense for the three months ended in Mar. 2026 was ₹-0.0 Mil. Its Operating Income for the three months ended in Mar. 2026 was ₹-5.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was ₹0.0 Mil.

Zenith Healthcare's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Zenith Healthcare did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Zenith Healthcare Interest Expense Historical Data

* Premium members only.

The historical data trend for Zenith Healthcare's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Healthcare Interest Expense Chart

Zenith Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 -0.00 -0.14 -0.12 -0.09

Zenith Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.04 -0.01 -0.02 -0.02
BOM:530665
61GF Score
Zenith Healthcare Ltd BOM:530665
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Healthcare Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-0.1 Mil mean?
Zenith Healthcare (BOM:530665) has a Interest Expense of ₹-0.1 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Zenith Healthcare and its competitors.
Is Zenith Healthcare's Interest Expense too high?
Zenith Healthcare's current Interest Expense is ₹-0.1 Mil. Overall, Zenith Healthcare has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenith Healthcare's Interest Expense compare to ZTS?
Zenith Healthcare's Interest Expense of ₹-0.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Zenith Healthcare and its competitors. Zenith Healthcare's current Interest Expense is ₹-0.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Zenith Healthcare (BOM:530665) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹3.62, compared to a current price of ₹3.09 — trading 14.6% below its estimated fair value. The current Interest Expense is ₹-0.1 Mil. Zenith Healthcare's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Zenith Healthcare (BOM:530665), the current Interest Expense is ₹-0.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenith Healthcare (BOM:530665) Overvalued in 2026?

Based on GuruFocus' analysis, Zenith Healthcare stock appears to be undervalued. The current stock price of ₹3.09 is trading 14.6% below its estimated GF Value™ of ₹3.62. GuruFocus considers Zenith Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:530665:

  • Interest Expense: ₹-0.1 Mil
  • GF Value™: ₹3.62 vs. price of ₹3.09 (14.6% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the BOM:530665 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zenith Healthcare Business Description

Address Prahladnagar Cross Road, S. G. Road, 504, Iscon Elegance, Near Ananddham Jain Derasar, Ahmedabad, GJ, IND, 380051
Zenith Healthcare Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and trading of pharmaceutical formulations. The company also undertakes contracts for manufacturing business. It manufactures pharmaceutical formulations in the form of Tablets, Capsules, Oral liquids, and injectables. The company sells its products in India and also exports internationally.
61GF Score

Get the complete analysis for BOM:530665

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.09
Price
₹3.62
GF Value